StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Precigen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Precigen's operating cash flow for the twelve months ending Jun 30, 2026 was -$114.17M. For fiscal 2025 it was -$87.83M. The highest annual figure on record is $35.67M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$87.83M–
FY2024Dec 31, 2024-$68.17M–
FY2023Dec 31, 2023-$66.93M–
FY2022Dec 31, 2022-$65.05M–
FY2021Dec 31, 2021-$55.77M–
FY2020Dec 31, 2020-$77.02M–
FY2019Dec 31, 2019-$135.93M–
FY2018Dec 31, 2018-$124.24M–
FY2017Dec 31, 2017-$103.72M–
FY2016Dec 31, 2016-$48.99M-237.3%
FY2015Dec 31, 2015$35.67M–
FY2014Dec 31, 2014-$19.86M–
FY2013Dec 31, 2013-$53.68M–
FY2012Dec 31, 2012-$61.53M–
FY2011Dec 31, 2011-$81.76M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$17.81M–
Q1 FY2026Mar 31, 2026-$43.83M–
Q4 FY2025Dec 31, 2025-$23.46M–
Q3 FY2025Sep 30, 2025-$29.07M–
Q2 FY2025Jun 30, 2025-$18.98M–
Q1 FY2025Mar 31, 2025-$16.33M–
Q4 FY2024Dec 31, 2024-$8.24M–
Q3 FY2024Sep 30, 2024-$22.73M–
Q2 FY2024Jun 30, 2024-$23.11M–
Q1 FY2024Mar 31, 2024-$14.09M–
Q4 FY2023Dec 31, 2023-$15.77M–
Q3 FY2023Sep 30, 2023-$17.01M–
Q2 FY2023Jun 30, 2023-$15.77M–
Q1 FY2023Mar 31, 2023-$18.39M–
Q4 FY2022Dec 31, 2022-$15.40M–
Q3 FY2022Sep 30, 2022-$23.81M–
Q2 FY2022Jun 30, 2022-$7.05M–
Q1 FY2022Mar 31, 2022-$18.78M–
Q4 FY2021Dec 31, 2021-$14.59M–
Q3 FY2021Sep 30, 2021-$17.02M–
Q2 FY2021Jun 30, 2021-$7.78M–
Q1 FY2021Mar 31, 2021-$16.38M–
Q4 FY2020Dec 31, 2020-$16.47M–
Q3 FY2020Sep 30, 2020-$19.00M–
Q2 FY2020Jun 30, 2020-$13.81M–
Q1 FY2020Mar 31, 2020-$27.74M–
Q4 FY2019Dec 31, 2019-$32.14M–
Q3 FY2019Sep 30, 2019-$27.15M–
Q2 FY2019Jun 30, 2019-$33.40M–
Q1 FY2019Mar 31, 2019-$43.23M–
Q4 FY2018Dec 31, 2018-$37.36M–
Q3 FY2018Sep 30, 2018-$28.82M–
Q2 FY2018Jun 30, 2018-$28.17M–
Q1 FY2018Mar 31, 2018-$29.89M–
Q4 FY2017Dec 31, 2017-$33.88M–
Q3 FY2017Sep 30, 2017-$22.01M–
Q2 FY2017Jun 30, 2017-$23.14M–
Q1 FY2017Mar 31, 2017-$24.69M–
Q4 FY2016Dec 31, 2016-$17.21M–
Q3 FY2016Sep 30, 2016-$15.73M–

More Precigen figures

See a number that looks wrong?